Lung cancer screening with spiral CT. Baseline results of the randomized DANTE trial

Maurizio Infante, Fabio Romano Lutman, Silvio Cavuto, Giorgio Brambilla, Giuseppe Chiesa, Eliseo Passera, Enzo Angeli, Maurizio Chiarenza, Giuseppe Aranzulla, Umberto Cariboni, Marco Alloisio, Matteo Incarbone, Alberto Testori, Anna Destro, Federico Cappuzzo, Massimo Roncalli, Armando Santoro, Gianluigi Ravasi

Research output: Contribution to journalArticle

Abstract

Background: Despite the high survival rates reported for screening-detected cases, the potential of screening of high-risk subjects for reducing lung cancer mortality is still unproven. We herewith present the baseline results of a randomized trial comparing screening for lung cancer with annual spiral computed tomography (CT) versus a yearly clinical review. Methods: Male subjects, 60-74 years old, and smokers of 20+ pack-years were enrolled. All participants received a baseline medical examination, chest X-rays (CXR) and sputum cytology upon accrual. Subjects randomized in the spiral CT group received a spiral CT scan at baseline, then yearly for the following 4 years. For controls, a yearly clinical examination was scheduled for the following 4 years. Results: 2472 subjects were randomized (1276 spiral CT arm, 1196 controls). Age, smoking exposure and co-morbid conditions were similar in the two groups. In the spiral CT group, 28 lung cancers were detected, 13 of which were visible in the baseline chest X-rays (overall prevalence 2.2%). Sixteen out of 28 tumours (57%) were stage I, and 19 (68%) were resectable. In the control group, eight cases were detected by the baseline chest X-rays (prevalence rate 0.67%), four (50%) were stage I, and six (75%) were resectable. Conclusions: Baseline lung cancer detection rate in the spiral CT arm was higher than in most published studies. The stage I detection rate was increased four-fold by spiral CT versus chest X-rays. However, more tumours in an advanced stage were also detected by CT. The high resection rate of screening-detected patients suggests a possible increase in cure rate. However, longer follow-up is required for definitive conclusions. This trial has been registered at www.Clinicaltrials.gov, registration No. NCT00420862.

Original languageEnglish
Pages (from-to)355-363
Number of pages9
JournalLung Cancer
Volume59
Issue number3
DOIs
Publication statusPublished - Mar 2008

Keywords

  • Lung cancer
  • Randomized trial
  • Screening
  • Spiral CT scan

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Lung cancer screening with spiral CT. Baseline results of the randomized DANTE trial'. Together they form a unique fingerprint.

  • Cite this